Joe Root had 17 Test 100s in his first 9 years. He has 24 in the last 4. How did he do it? This data-centric long-read details the change in his decisions, tactics and mindset.

ArriVent BioPharma's furmonertinib demonstrates robust efficacy, CNS penetration, and tolerability in early trials. Read why ...

Joe Rogan is bullish on Gable Steveson’s UFC future. Admittedly, it’s hard not to be impressed even if Steveson isn’t signed ...

In addition, running back Trevor Etienne and linebacker Bam Martin-Scott, continue to make their respective impacts on ...

The 11 current UFC champions will fall under one of the following categories: Immovable Objects: This champion is perceived ...

Valued at £40m, the 23-year-old Akliouche would be a more cost-effective signing than Semenyo, and he might even have more ...

Discover why Carvana (CVNA) faces 54% downside risk. Learn about EBITDA threats, regulatory investigations, and key risks for ...

After a lengthy downturn, the biotech industry finally gathered momentum in 2025. Key readouts in obesity, infectious disease ...

This newsletter is available daily Monday through Friday, exclusively for SportsLine subscribers. If you received this as a ...

A tribute to Shashi Anand, the radical filmmaker who exposed Calcutta’s invisible labour through documentary cinema.

This luxury hybrid sedan is now more affordable than the base Toyota Prius, offering exceptional value, reliability, and ...

As Polymarket and Kalshi continue to grow in popularity, they have worked with social media accounts claiming to be breaking ...